Drug Trial Radar · NCT05909904
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Head and Neck Squamous Cell Carcinoma
Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
160
Actual
Start
Aug 2, 2023
Primary completion
Jun 17, 2025
Study completion Jul 23, 2026
Sponsor
- Lead sponsor
- BeiGeneBeOne Medicines (BeiGene) (ONC)
- Sponsor type
- Industry
- First posted
- Jun 18, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is designed to evaluate the efficacy and safety of tislelizumab and tislelizumab in combination with investigational agent(s) in first-line recurrent or metastatic (R/M) head and neck squamous cell carcinoma (HNSCC).
Conditions
- Head and Neck Squamous Cell Carcinoma
- Head and Neck Cancer
Interventions
TislelizumabDrug
Administered intravenously
BGB-A425Drug
Administered intravenously
LBL-007Drug
Administered intravenously
Primary outcomes
What the sponsor says the trial is designed to measure.
- Objective Response Rate (ORR)Time frame: Up to 21.2 months
Locations
73 sites in 14 countries. Site status is shown where the registry gives one.
Valkyrie Clinical Trials
Los Angeles, California
Stanford Medicine
Stanford, California
Rocky Mountain Cancer Centers, Llp(Us Oncology Research)
Lone Tree, Colorado
Florida Cancer Specialist Research Institute Lake Nona
Orlando, Florida
Florida Cancer Specialist Research Institute Panhandle
Tallahassee, Florida
University of Kentucky Markey Cancer Center
Lexington, Kentucky
Oncology and Hematology Associates of Southwest Virginia, Inc (Us Oncology Research)
Blacksburg, Virginia
Cancer Care Northwest
Spokane Valley, Washington
Northwest Cancer Specialist, Pc(Us Oncology Research)
Vancouver, Washington
Nepean Hospital
Kingswood, New South Wales, Australia
North Shore Private Hospital
St Leonards, New South Wales, Australia
Gold Coast Private Hospital
Gold Coast, Queensland, Australia
Greenslopes Private Hospital
Greenslopes, Queensland, Australia
Cancer Research South Australia
Adelaide, South Australia, Australia
Northeast Health Wangaratta
Wangaratta, Victoria, Australia
St John of God, Murdoch
Murdoch, Western Australia, Australia
British Columbia Cancer Agency the Vancouver Centre
Vancouver, British Columbia, Canada
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital
Hefei, Anhui, China
Beijing Tongren Hospital, Cmu
Beijing, Beijing Municipality, China
Beijing Cancer Hospital
Beijing, Beijing Municipality, China
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China
Fujian Cancer Hospital
Fuzhou, Fujian, China
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, China
Sun Yat Sen University Cancer Center
Guangzhou, Guangdong, China
The Tumor Hospital Affiliated to Guangxi Medical University
Nanning, Guangxi, China
Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology
Wuhan, Hubei, China
Xiangya Hospital of Central South University
Changsha, Hunan, China
The Second Xiangya Hospital of Central South University
Changsha, Hunan, China
Hunan Cancer Hospital
Changsha, Hunan, China
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China
The First Affiliated Hospital of Nanchang University Branch Donghu
Nanchang, Jiangxi, China
The First Hospital of Jilin University
Changchun, Jilin, China
Shandong Cancer Hospital
Jinan, Shandong, China
Shanghai East Hospital
Shanghai, Shanghai Municipality, China
Sichuan Cancer Hospital and Institute
Chengdu, Sichuan, China
West China Hospital, Sichuan University
Chengdu, Sichuan, China
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, China
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China
Zhejiang Cancer Hospital
Hangzhou, Zhejiang, China
Showing 40 of 73 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.